Top Markets
#1 MarsCoin MarsCoin +42.00%
#2 Palladium Network Palladium Network +27.94%
#3 Siren Siren +26.66%
#4 Status Status +21.64%
#5 Useless Coin Useless Coin +15.44%
#6 BankrCoin BankrCoin +15.32%
#7 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +15.19%
#8 Ankr Network Ankr Network +12.21%
#9 Hive Hive +11.43%
#10 Bedrock Bedrock +11.42%
Coin of the day
MarsCoin MarsCoin
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Armata Pharmaceuticals, Inc. Armata Pharmaceuticals, Inc.

Armata Pharmaceuticals, Inc.

ARMP
Classement en actions #18297
Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology... Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology enterprise with a global focus on creating specialized bacteriophage therapeutics. Its primary objective is to tackle infections that have developed resistance to standard antibiotics. The company's innovative treatments are developed utilizing its exclusive bacteriophage-based technology platform. Within its product pipeline are several significant candidates: AP-SA02, designed for the treatment of Staphylococcus aureus bacteremia; AP-PA02, targeting Pseudomonas aeruginosa; and AP-PA03, intended to address pneumonia. Additionally, Armata has forged a collaborative agreement with Merck & Co. to further the development of synthetic bacteriophage candidates aimed at specific, yet unrevealed, infectious disease agents. The company's main offices are located in Marina del Rey, California.
Prix de l'action
$5.59
Dernière synchronisation: 2026-09-02
Capitalisation boursière
$205.21M
Changement (1 jour)
6.27%
Changement (1 an)
86.33%
Pays
US
Échange Armata Pharmaceuticals, Inc. (ARMP)

Catégorie

Healthcare
Ratio P/B pour Armata Pharmaceuticals, Inc. (ARMP)
Ratio P/B au 2026 TTM : 0
Selon les derniers rapports financiers et le cours de l'action de Armata Pharmaceuticals, Inc., le ratio cours/valeur comptable actuel (TTM) est 0. À la fin de 2026, le ratio P/B était de 0.
Historique du ratio P/B pour Armata Pharmaceuticals, Inc. de 2026 à 2026
Ratio P/B à la fin de chaque année
Année Ratio P/B Changez
Pas assez de données pour les dates fournies.
Ratio P/B pour des entreprises similaires ou concurrentes
Entreprise Ratio P/B Différence de Ratio P/B Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.828 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 7.5116 -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 8.2199 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 3.9942 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH